Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes

One of the proven methods to prevent and inhibit viral infections is to use antibodies to block the initial Receptor Binding Domain (RBD) of SARS-CoV-2 S protein and avoid its binding with the host cells. Thus, developing these RBD-targeting antibodies would be a promising approach for treating the...

Descripción completa

Detalles Bibliográficos
Autores principales: Traboulsi, Hassan, Khedr, Mohammed A., Elgorashe, Rafea, Al-Faiyz, Yasair, Negm, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662835/
https://www.ncbi.nlm.nih.gov/pubmed/34909055
http://dx.doi.org/10.1016/j.arabjc.2021.103631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662835/
https://www.ncbi.nlm.nih.gov/pubmed/34909055
http://dx.doi.org/10.1016/j.arabjc.2021.103631

Ejemplares similares